NCT01702987View on ClinicalTrials.gov

Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
MyopathyHMG COA Reductase Inhibitor Adverse ReactionHypercholesterolemia
Interventions
DIETARY_SUPPLEMENT

ubiquinol

ubiquinol supplementation was given for 1 month to 12 patients

DIETARY_SUPPLEMENT

placebo

placebo (identical in appearance to ubiquinol) was given for 1 month to 9 patients

DRUG

statin

statin was given for 1 month to 21 patients

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT01702987 - Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS | Biotech Hunter | Biotech Hunter